CNBC Investing Club: Cramer's Morning Take on Linde PLC 10/29/26
Summary
Jim Cramer highlights Eli Lilly’s strong earnings and its focus on improving drug tolerability, while noting that excluding its struggling home care business would reveal double-digit growth. He also discusses the success of the Medicare Bridge program and previews upcoming earnings from Amazon, Intel, Starbucks, and FedEx, offering specific investment perspectives on each company.
Topics discussed
Sponsorship: CDW and Lenovo AI PCs
Introduction to CNBC Morning Take preview
Eli Lilly's strong quarter and drug tolerability
Market overview: Merck, J&J, and Lindy performance
Investment strategy and upcoming earnings preview
Specific stock takes: Amazon, Intel, Starbucks, FedEx
Legal disclaimer and opinions statement
Sponsorship: Southwest Airlines
Listen ad-free on Castria